BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29114172)

  • 1. Theranostic Probes for Cancer Imaging.
    Wang F; Zhu L; Yang K; Park D
    Contrast Media Mol Imaging; 2017; 2017():1863803. PubMed ID: 29114172
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-invasive molecular imaging and theranostic probes.
    Mottaghy FM
    Methods; 2017 Nov; 130():1-3. PubMed ID: 28987915
    [No Abstract]   [Full Text] [Related]  

  • 3. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
    Shahbazi R; Ozpolat B; Ulubayram K
    Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanin-Based Contrast Agents for Biomedical Optoacoustic Imaging and Theranostic Applications.
    Longo DL; Stefania R; Aime S; Oraevsky A
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28783106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
    Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
    Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin Nanovectors in Cancer Therapy and Imaging.
    Parodi A; Miao J; Soond SM; Rudzińska M; Zamyatnin AA
    Biomolecules; 2019 Jun; 9(6):. PubMed ID: 31195727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theranostic Upconversion Nanobeacons for Tumor mRNA Ratiometric Fluorescence Detection and Imaging-Monitored Drug Delivery.
    Ding Q; Zhan Q; Zhou X; Zhang T; Xing D
    Small; 2016 Nov; 12(43):5944-5953. PubMed ID: 27647762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PET/CT: Molecular Imaging and Theranostics for Radionuclide Therapy].
    Derlin T; Bengel FM
    Pneumologie; 2017 Jan; 71(1):48-62. PubMed ID: 28114710
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.
    Ma Y; Huang J; Song S; Chen H; Zhang Z
    Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear Medicine in Cancer Theranostics: Beyond the Target.
    Taïeb D; Hicks RJ; Pacak K
    J Nucl Med; 2016 Nov; 57(11):1659-1660. PubMed ID: 27445288
    [No Abstract]   [Full Text] [Related]  

  • 11. Aliphatic polyesters for medical imaging and theranostic applications.
    Nottelet B; Darcos V; Coudane J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt B):350-70. PubMed ID: 26614557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinspired approaches for cancer nanotheranostics.
    Evangelopoulos M; Tasciotti E
    Nanomedicine (Lond); 2017 Jan; 12(1):5-7. PubMed ID: 27876435
    [No Abstract]   [Full Text] [Related]  

  • 13. Coating microbubbles with nanoparticles for medical imaging and drug delivery.
    Tay LM; Xu C
    Nanomedicine (Lond); 2017 Jan; 12(2):91-94. PubMed ID: 27876447
    [No Abstract]   [Full Text] [Related]  

  • 14. Graphene Quantum Dots for Theranostics and Bioimaging.
    Schroeder KL; Goreham RV; Nann T
    Pharm Res; 2016 Oct; 33(10):2337-57. PubMed ID: 27207272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostic and nanotheranostic probes in nuclear medicine.
    Drude N; Tienken L; Mottaghy FM
    Methods; 2017 Nov; 130():14-22. PubMed ID: 28698069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biocompatible PEGylated bismuth nanocrystals: "All-in-one" theranostic agent with triple-modal imaging and efficient in vivo photothermal ablation of tumors.
    Li Z; Liu J; Hu Y; Li Z; Fan X; Sun Y; Besenbacher F; Chen C; Yu M
    Biomaterials; 2017 Oct; 141():284-295. PubMed ID: 28709019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Companion Diagnostics and Molecular Imaging.
    Puranik AD; Kulkarni HR; Baum RP
    Cancer J; 2015; 21(3):213-7. PubMed ID: 26049701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging.
    Elzoghby AO; Hemasa AL; Freag MS
    J Control Release; 2016 Dec; 243():303-322. PubMed ID: 27794493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theranostic Imaging of Yttrium-90.
    Wright CL; Zhang J; Tweedle MF; Knopp MV; Hall NC
    Biomed Res Int; 2015; 2015():481279. PubMed ID: 26106608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of iron oxide nanoparticle-based hybrid platforms for tumor imaging and therapy.
    Hu Y; Mignani S; Majoral JP; Shen M; Shi X
    Chem Soc Rev; 2018 Mar; 47(5):1874-1900. PubMed ID: 29376542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.